Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1988-3-7
pubmed:abstractText
In a population study, 10,000 men (aged 46-48 years) were invited to a health screening program. At follow-up, which was up to eight years later, 61 subjects had died from cancer; from 35 of these subjects, plasma samples were available that were obtained at the initial screening. These samples, together with samples from two living controls for each case, were analyzed for selenium, retinol, cholesterol, triglyceride, and a number of plasma proteins. Plasma selenium was significantly lower (p less than 0.05) in cases than in controls (means: 1.06 vs. 1.12 mumol/l). The proportion of cases increased significantly from the highest to the lowest quintile of plasma selenium, and the relative risk for cancer death was 3.8 times higher in the lowest quintile compared with the highest. Mean plasma retinol was similar in cases (2.53 mumol/l) and controls (2.56 mumol/l). Cases and controls also had similar values for plasma cholesterol, triglyceride, uric acid, apolipoprotein B, orosomucoid, prealbumin, retinol-binding protein, and beta 2-microglobulin. Apolipoprotein AI in plasma was lower among cases (p less than 0.025). Cases smoked significantly more than controls did (p less than 0.05). Data indicate that low plasma selenium was a risk factor for cancer death in middle-aged men who lived in the same area. Further studies are necessary to establish whether differences in selenium intake, selenium metabolism, or other factors related to selenium are responsible for the relations observed. At present, the available data do not justify selenium supplementation programs in the whole population.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins A, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Orosomucoid, http://linkedlifedata.com/resource/pubmed/chemical/Retinol-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Retinol-Binding Proteins, Plasma, http://linkedlifedata.com/resource/pubmed/chemical/Selenium, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/Uric Acid, http://linkedlifedata.com/resource/pubmed/chemical/Vitamin A, http://linkedlifedata.com/resource/pubmed/chemical/Vitamin E, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin
pubmed:status
MEDLINE
pubmed:issn
0163-5581
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
221-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3124081-Apolipoprotein A-I, pubmed-meshheading:3124081-Apolipoproteins A, pubmed-meshheading:3124081-Apolipoproteins B, pubmed-meshheading:3124081-Cholesterol, pubmed-meshheading:3124081-Humans, pubmed-meshheading:3124081-Male, pubmed-meshheading:3124081-Middle Aged, pubmed-meshheading:3124081-Neoplasms, pubmed-meshheading:3124081-Orosomucoid, pubmed-meshheading:3124081-Retinol-Binding Proteins, pubmed-meshheading:3124081-Retinol-Binding Proteins, Plasma, pubmed-meshheading:3124081-Risk Factors, pubmed-meshheading:3124081-Selenium, pubmed-meshheading:3124081-Smoking, pubmed-meshheading:3124081-Sweden, pubmed-meshheading:3124081-Triglycerides, pubmed-meshheading:3124081-Uric Acid, pubmed-meshheading:3124081-Vitamin A, pubmed-meshheading:3124081-Vitamin E, pubmed-meshheading:3124081-beta 2-Microglobulin
pubmed:year
1987
pubmed:articleTitle
Low plasma selenium as a risk factor for cancer death in middle-aged men.
pubmed:affiliation
Department of Clinical Chemistry, Malmö General Hospital, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't